A recent study shows measles-mumps-rubella-varicella (MMRV) vaccination is associated with an increased risk of fever and seizure in young children, above that already associated with measles-containing vaccines.
Updates on recent FDA approvals, appointments, acquisitions and alliances in the pharmaceutical industry.
The U.S. Food and Drug Administration has launched two new websites relating to drug safety.
U.S. investigators are determining if there is evidence to support the efficacy of IVIG therapy specifically in autoimmune mucocutaneous blistering diseases (AMBDs).
The U.S. government has begun to stockpile a new version of the smallpox vaccine that is designed to close a gap that left millions vulnerable to a bioterror attack.
University of Missouri researchers are working on a vaccine to improve infants’ immune systems, which are susceptible to diseases and infections such as jaundice and E. coli, right after birth.
The Food and Drug Administration has approved two new drugs for the treatment of acute attacks of hereditary angioedema.
The recently enacted healthcare legislation contains a new incentive for biotech companies known as the Qualifying Therapeutic Discovery Project Credit (Therapeutic Credit).
A new report analyzes and assesses the target pipeline for each of the coagulation factors used for systemic and topical administration.
A diagnostic blood test for Alzheimer’s disease has been developed by OPKO Health Inc.
A new study to assess patient awareness of medications prescribed during a hospital visit found that many patients believed they were receiving a medication they were not, and most were unable to recall the name of at least one medication they had been prescribed during their stay.
Update on vaccines for swine flu, AIDS, HPV and malaria, universal flu vaccines, clinical studies and more.